Unique ID issued by UMIN | C000000359 |
---|---|
Receipt number | R000000457 |
Scientific Title | Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507) |
Date of disclosure of the study information | 2006/03/15 |
Last modified on | 2013/04/17 14:15:05 |
Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
Double-unit cord blood transplantation(C-SHOT 0507)
Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
Double-unit cord blood transplantation(C-SHOT 0507)
Japan |
Hematological malignancies
Hematology and clinical oncology |
Malignancy
YES
To study feasibility and effectiveness of double-unit cord blood transplantation
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Event-free survival at one year after double-unit cord blood transplantation
Time of hematopoietic engraftment, treatment-related toxicity, incidence and severity of acute and chronic graft versus host disease, disease-free survival and overall survival at 1-year
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Maneuver |
To study feasibility and effectiveness of double-unit cord blood (CB) transplantation in patients with hematological malignancies requiring hematopoietic stem cell transplantation without any available single-unit CB.
Not applicable |
55 | years-old | > |
Male and Female
1) Patient with poor risk hematologic malignancies
2) Patient who receives double-unit CBT as first stem cell transplantation
3) Age: less than 55 years old
4) Patient without active infection at starting conditioning chemoradiatherapy
5) HIV-antibody negative patient
6) Patient who has no HLA-matched or one antigen-mismatched relatives
7) Patient who has no HLA-matched unrelated donor, or who requires urgent transplant even if he/she has HLA-matched unrelated donor
8) Patient who has no single CB unit with cell dose of more than 2.5x107/kg and 2 or more HLA antigen mismatches
1) ECOG's performance status; 2 or more
2) Ejection fraction(EF); less than 50%
3) SaO2; more than 93% in room air
4) Serum creatinine; 1.3mg/dl or greater
5) Total bilirubin; 1.6mg/dl or greater, or GOT; 2 x normal value or greater
6) Down's syndrome
7) Fanconi's anemia
70
1st name | |
Middle name | |
Last name | Shun-ichi Kato, Shunro Kai |
1) Tokai University, School of Medicine
2) Hyogo College of Medicine
1) Research Center for regenerative medicine 2) The Department of Transfusion Medicine
1) Boseidai, Isehara-city, Kanagawa 2) 1-1,Mukogawa-cho,Nishinomiya,Hyogo
0463-93-1121
1st name | |
Middle name | |
Last name | Shiro Yoshiba |
Registry office of double-unit cord blood transplantation
Research Center for regenerative medicine
Boseidai, Isehara-city, Kanagawa
0463-93-1121
A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.
A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.
Japan
NO
2006 | Year | 03 | Month | 15 | Day |
Unpublished
Completed
2006 | Year | 03 | Month | 02 | Day |
2006 | Year | 03 | Month | 01 | Day |
2010 | Year | 03 | Month | 01 | Day |
2010 | Year | 09 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
2006 | Year | 03 | Month | 15 | Day |
2013 | Year | 04 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000457